Injecting into the same small area over and over can cause lipohypertrophy, which is a buildup of fat and scar tissue under the skin
Weight loss varies by indication and dose, with approximately 15-21% reduction at higher doses in obesity trials and typically lower percentages in type 2 diabetes studies
Well monitor your progress and make any necessary adjustments to your treatment plan
, to fulfill five or more such products per calendar month), compounding pharmacies must ensure that compounded tirzepatide products do not contain the same, similar, or easily substitutable dosage strength, or that such products are not used by the same route of administration as the commercially available product
People seeking a convenient L-Carnitine supplement
Lilly's currently approved injection, Zepbound, and Novo Nordisk's Wegovy have shown weight loss of roughly 15% to 20% in different trials, according to Reuters, while Lilly's oral obesity pill, Foundayo, has delivered about 11% weight loss
